This latest “it’s a launch Jim but not as we know it “ is just farcical. To announce that Viraleze product is relaunched (coincidentally and conveniently on the very last day of the financial year) is as embarrassing as it is disingenuous IMO.
It’s 6 days now after SPL told the ASX that Viraleze is relaunched in Europe but it’s not actually in stores of course and looks like it still not even available online.
However this type of thing should not come as a surprise. It’s just what JF and Starpharma do, it’s in their DNA.
Below is an oldie but a goodie and just another example IMO of why investors must take a deep breath and take caution before getting excited about anything that comes out of Jackie Fairley’s mouth.
April 2016 Bell Direct interview of Jackie Fairley by Julia Lee. Q: What do you see as key catalysts in the next twelve months? A: For the VivaGel BV product we’ve obviously secured approval in Europe, and we’ll be looking forward to the launch of that product in Europe.
That was a word for word direct quote/transcript where Jackie indicated to the investment community that a product launch is expected in the next 12 months.
But the reality was … 2016: 2017: 2018: June 2019: VivaGel BV finally launched in Europe
